Jeanine Kamphuis
Psychiatrist and researcher at the Department for Mood Disorders, University Hospital Groningen (UMCG)
Data updated
Research Footprint
Jeanine Kamphuis appears in 12 tracked papers (2020–2026), most studied alongside Ketamine, Esketamine and Psilocybin, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Anxiety Disorders.
Most-cited paper: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (1057 citations).
Frequent co-authors: Robert Schoevers, Jolien Veraart and Sanne Smith-Apeldoorn.
Background & Research
Jeanine Kamphuis is a psychiatrist and researcher at the Department for Mood Disorders in the University Hospital Groningen (UMCG). Her work focuses on treatment-resistant depression and the clinical use of mind-altering drugs such as ketamine and classic psychedelics. She also coordinates the ketamine treatment program started in 2017 at UMCG.
Key Impact
She studies ketamine, esketamine, and classic psychedelics for treatment-resistant psychiatric disorders, including depression, and is a coauthor on multiple psychedelic/ketamine reviews and clinical studies.
Collaboration Network
32 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Jeanine Kamphuis is associated with.